144 related articles for article (PubMed ID: 8109900)
1. An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease.
Mizuno Y; Matuda S; Yoshino H; Mori H; Hattori N; Ikebe S
Ann Neurol; 1994 Feb; 35(2):204-10. PubMed ID: 8109900
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease.
Hattori N; Tanaka M; Ozawa T; Mizuno Y
Ann Neurol; 1991 Oct; 30(4):563-71. PubMed ID: 1665052
[TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
4. Association between the gene encoding the E2 subunit of the alpha-ketoglutarate dehydrogenase complex and Parkinson's disease.
Kobayashi T; Matsumine H; Matuda S; Mizuno Y
Ann Neurol; 1998 Jan; 43(1):120-3. PubMed ID: 9450778
[TBL] [Abstract][Full Text] [Related]
5. Distribution of the alpha-ketoglutarate dehydrogenase complex in rat brain.
Calingasan NY; Baker H; Sheu KF; Gibson GE
J Comp Neurol; 1994 Aug; 346(3):461-79. PubMed ID: 7995856
[TBL] [Abstract][Full Text] [Related]
6. Defects of cytochrome c oxidase in the substantia nigra of Parkinson's disease: and immunohistochemical and morphometric study.
Itoh K; Weis S; Mehraein P; Müller-Höcker J
Mov Disord; 1997 Jan; 12(1):9-16. PubMed ID: 8990048
[TBL] [Abstract][Full Text] [Related]
7. Degeneration of the centré median-parafascicular complex in Parkinson's disease.
Henderson JM; Carpenter K; Cartwright H; Halliday GM
Ann Neurol; 2000 Mar; 47(3):345-52. PubMed ID: 10716254
[TBL] [Abstract][Full Text] [Related]
8. Quantitative alpha-ketoglutarate dehydrogenase activity staining in brain sections and in cultured cells.
Park LC; Calingasan NY; Sheu KF; Gibson GE
Anal Biochem; 2000 Jan; 277(1):86-93. PubMed ID: 10610692
[TBL] [Abstract][Full Text] [Related]
9. Iron-dependent enzymes in Parkinson's disease.
Reichmann H; Janetzky B; Riederer P
J Neural Transm Suppl; 1995; 46():157-64. PubMed ID: 8821051
[TBL] [Abstract][Full Text] [Related]
10. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
Hill WD; Arai M; Cohen JA; Trojanowski JQ
J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
[TBL] [Abstract][Full Text] [Related]
11. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease.
Dexter DT; Sian J; Rose S; Hindmarsh JG; Mann VM; Cooper JM; Wells FR; Daniel SE; Lees AJ; Schapira AH
Ann Neurol; 1994 Jan; 35(1):38-44. PubMed ID: 8285590
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
Anglade P; Vyas S; Javoy-Agid F; Herrero MT; Michel PP; Marquez J; Mouatt-Prigent A; Ruberg M; Hirsch EC; Agid Y
Histol Histopathol; 1997 Jan; 12(1):25-31. PubMed ID: 9046040
[TBL] [Abstract][Full Text] [Related]
13. alpha-Ketoglutarate dehydrogenase contributes to production of reactive oxygen species in glutamate-stimulated hippocampal neurons in situ.
Zündorf G; Kahlert S; Bunik VI; Reiser G
Neuroscience; 2009 Jan; 158(2):610-6. PubMed ID: 18996448
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease.
Hattori N; Ikebe S; Tanaka M; Ozawa T; Mizuno Y
Adv Neurol; 1993; 60():292-6. PubMed ID: 8380521
[No Abstract] [Full Text] [Related]
15. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
16. Implications of enzyme deficiencies on mitochondrial energy metabolism and reactive oxygen species formation of neurons involved in rotenone-induced Parkinson's disease: a model-based analysis.
Berndt N; Holzhütter HG; Bulik S
FEBS J; 2013 Oct; 280(20):5080-93. PubMed ID: 23937586
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease.
Pearce RK; Owen A; Daniel S; Jenner P; Marsden CD
J Neural Transm (Vienna); 1997; 104(6-7):661-77. PubMed ID: 9444566
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of the alpha-ketoglutarate dehydrogenase complex alter [1-13C]glucose and [U-13C]glutamate metabolism in cerebellar granule neurons.
Santos SS; Gibson GE; Cooper AJ; Denton TT; Thompson CM; Bunik VI; Alves PM; Sonnewald U
J Neurosci Res; 2006 Feb; 83(3):450-8. PubMed ID: 16416424
[TBL] [Abstract][Full Text] [Related]
20. Oxidative mechanisms in nigral cell death in Parkinson's disease.
Jenner P
Mov Disord; 1998; 13 Suppl 1():24-34. PubMed ID: 9613715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
